benign prostatic hyperplasia | Research | Treatment | 10 pages | source: Prostate | Added Jun 30, 2019
Evaluating outcomes of prostate botulinum toxin-A injections for benign prostatic hyperplasia
This article investigated the safety and effectiveness of botulinum toxin-A (BTX-A) injections for the treatment of the lower urinary tract symptoms (LUTS) caused by benign prostatic hyperplasia (BPH). The authors concluded that BTX-A injections are a safe and effective treatment option for these patients.
hypertension | Research | Treatment | 10 pages | source: Journal of hypertension | Added Jun 29, 2019
Renal denervation reduces blood pressure in patients with moderate resistant hypertension
This study examined the effect of renal denervation on blood pressure in patients with moderate resistant hypertension. The authors concluded that renal denervation can significantly reduce blood pressure in patients with moderate resistant hypertension.
hypertension | Research | Treatment | 10 pages | source: American journal of hypertension | Added Jun 27, 2019
Can renal denervation or spironolactone reduce blood pressure variability in resistant hypertension?
This study compared the effects of spironolactone (Aldactone) and renal denervation treatment on blood pressure variation in patients with resistant hypertension. The authors concluded that spironolactone was more effective at reducing blood pressure but renal denervation significantly reduced blood pressure variability.
hypertension | Research | Treatment | 5 pages | source: The American journal of cardiology | Added Jun 25, 2019
Benazepril plus amlodipine results in fewer cardiovascular events than benazepril plus hydrochlorothiazide
The authors evaluated the effectiveness of two different drug combinations in reducing cardiovascular events in patients with hypertension and coronary artery disease.
hypertension | Research | Treatment | 8 pages | source: Journal of hypertension | Added Jun 23, 2019
Does time of treatment affect valsartan in reducing blood pressure?
This study investigated whether taking a drug to reduce high blood pressure at bedtime is more effective than taking the drug in the morning.
hypertension | Research | Treatment | 10 pages | source: Medicine | Added Jun 21, 2019
Is eplerenone an effective anti-hypertensive drug in overweight patients?
This study investigated if eplerenone (Inspra) reduces blood pressure (BP) in overweight or obese patients. They found that this treatment was effective at lowering BP, especially in elderly patients.
hypertension | Research | 10 pages | source: PLOS ONE | Added Jun 19, 2019
What a rise in blood pressure in the morning means for your heart health
This study examined the rate of rise in blood pressure in patients after waking along with having high blood cholesterol and whether they increase the risk of having a heart attack or stroke.
hypertension | Research | 6 pages | source: Stroke | Added Jun 16, 2019
Low GFR; a high risk for recurrent strokes
This study examined the association of low glomerular filtration rate (GFR) with stroke risk and evaluated whether renin-angiotensin system modulator therapy reduces the risk of strokes among patients with low GFR.
hypertension | Research | 8 pages | source: International Journal of Cardiology | Added Jun 14, 2019
Can abnormal left ventricular function predict diastolic dysfunction?
The authors assessed the prevalence of left ventricular diastolic dysfunction and its relation to function of the longitudinal fibers of the heart in asymptomatic patients with arterial hypertension.
hypertension | Research | Lifestyle | 10 pages | source: Journal of hypertension | Added Jun 12, 2019
The benefit of aerobic exercise for patients with resistant hypertension
This study looked at the effect of aerobic exercise on blood pressure and blood flow in patients with resistant hypertension. The authors concluded that light and moderate intensity aerobic exercise can improve blood pressure in patients with resistant hypertension.
